
Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year.
Despite the decline, earnings exceeded both the company’s guidance range of 17 cents to 21 cents and the consensus estimate of 20 cents.